Alberto Fernández-Tejada

12PUBLICATIONS
57CO-AUTHORS
Molecular targetsGlycoconjugatesPowder and particle technologyMedical molecular engineering of nucleic acids and proteinsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 28, 2026
Synthesis and In Vivo Immunological Evaluation of Novel Saponin-Antigen Conjugates Incorporating Tumor-Associated Carbohydrate and Peptide Epitopes.

|Nov 20, 2025
Design, synthesis and immunological evaluation of CRM<sub>197</sub>-based immunogens functionalized with synthetic scaffolds displaying a tumor-associated MUC1 glycopeptide.

Carlo Pifferi, David Goyard, Leire Aguinagalde

|Dec 08, 2024
Development of a New Vaccine Adjuvant System Based on the Combination of the Synthetic TLR4 Agonist FP20 and a Synthetic QS-21 Variant.

Mohammed Monsoor Shaik, Samuel Pasco, Alessio Romerio

|Apr 03, 2023
Development of synthetic, self-adjuvanting, and self-assembling anticancer vaccines based on a minimal saponin adjuvant and the tumor-associated MUC1 antigen.

Carlo Pifferi, Leire Aguinagalde, Ane Ruiz-de-Angulo

|Oct 14, 2021
Design, synthesis, and initial immunological evaluation of glycoconjugates based on saponin adjuvants and the Tn antigen.

Roberto Fuentes, Leire Aguinagalde, Nagore Sacristán

|Aug 02, 2021
Advances in chemical probing of protein <i>O</i>-GlcNAc glycosylation: structural role and molecular mechanisms.

Abhijit Saha, Davide Bello, Alberto Fernández-Tejada

Pageof 2

Frequent Collaborators

5 joint publications

Carlo Pifferi

4 joint publications

Leire Aguinagalde

3 joint publications

Juan Anguita

3 joint publications

Roberto Fuentes